Definitive Contract 75D30121C12879
Award Date
9/29/21
Potential Completion Date
9/28/26
Potential Value
$4.5M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
State Of California Controllers Office
NAICS Category
541690 - Other Scientific and Technical Consulting Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,724,262 definitive cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for the Tuberculosis Trials Consortium. The contract has a completion date of December 31, 2021 and is not set aside for any special program. UCSF is an academic institution that has previously received federal contracts and grants from agencies such as the National Institutes of Health,...
The Centers for Disease Control and Prevention (CDC) awarded a $5,176,985.37 cost-no-fee definitive contract to King County, doing business as Public Health-Seattle & King County, to develop and evaluate interventions for identifying and treating latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. This contract, titled "TBESC 3 - Seattle and King County," does not have a set-aside designation, indicating it was competed on a full...
Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
This federal contract award, HHSD200201692351C, was issued by the Centers for Disease Control and Prevention (CDC) to the University of California, San Francisco (UCSF) to conduct a study on latent tuberculosis infection (LTBI) in Vietnam. The $749,187.00 firm fixed-price contract, awarded on September 29, 2016 without a set-aside, supports a collaboration between UCSF and the Vietnam National Lung Hospital to implement a pilot study on testing and treatment of LTBI among U.S. visa applicants...
This federal contract award to Kaiser Foundation Hospitals, a subsidiary of Kaiser Foundation Health Plan, Inc., supports the Centers for Disease Control and Prevention's (CDC) efforts to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The $5,223,415 definitive contract, awarded on September 29, 2021 without a set-aside, will fund the development, implementation, and evaluation of LTBI intervention...
This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...
Research Triangle Institute (RTI) International was awarded a $707,813 time and materials contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide cost effectiveness analysis services for the Tuberculosis Epidemiologic Studies Consortium III (TBESC-III). The contract calls for RTI to design and implement cost effectiveness analyses of clinical interventions to improve performance across the latent tuberculosis infection care cascade. RTI...
The Centers for Disease Control and Prevention (CDC) awarded The Regents of the University of California, San Francisco (UCSF) a $6,115,923.22 definitive cost-no-fee contract for the "National History of SARS-CoV-2 Infection" project. The contract has a completion date of May 31, 2024. UCSF, a public academic medical center and research university, has a long history of conducting biomedical research, clinical trials, and providing healthcare and technical services under federal...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF), a leading academic medical center and research institution. The contract, valued at $300,058, is for other functions and is a definitive, firm-fixed-price contract. It does not have a set-aside designation. The contract work is being performed in Atlanta, Georgia and has an ultimate completion date of December 31, 2018. UCSF has a strong...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...